Bruh, if the science is good then the pps will eventually be good, that's how biotech start-up work. You've never questioned the science but then you did believe
@Mason14's misleading "science" lol. You see, I don't see it as a gamble right now. Sure if the pps is at 30c right now and was consider "overvalue" then you can say it's a gamble but IMU will have $40M in cash at the start of the year and HER-Vaxx has some value after releasing very good Ph2 clinical trial results.
For argument sake, VAXINIA, OASIS and Azer-Cel all doesn't work and need more lab studies. What do you think the MC will drop to???? $200M so it's low risk given the MC is currently already $260M compared to other stocks which have $100M MC without anywhere near the potential of IMU.
(20min delay)